Biotech grants in Israel

Funds a full-scale plant scaling up fibre-based packaging with new or improved properties, designed from the start for recycling or reuse.

Funds converting a batch biotech process for making bio-based chemicals or materials into a continuous process with higher productivity and lower cost.

Pays a university-industry network to build and test new training curricula for bioeconomy skills like biomanufacturing, ecodesign and circularity.

Closed

Funds research teams that use gene and epigenome editing to engineer safer, more effective off-the-shelf cell therapies for one chosen disease area.

Closed

Funds bio-based and nature-based remediation projects that clean up polluted soil, sediment and water.

Closed

Pays one coordination team to run the EU-wide policy forum that gets governments, regulators and industry to agree on which animal-testing-alternative methods are ready for official use.

Closed

Funds the coordination of up to ten existing advanced-therapy research centres into one European network, with a shared roadmap for scaling up gene and cell therapy manufacturing.

Closed

Funds a pan-European network of 10-18 startup and scaleup hubs that can pass on up to EUR 60,000 per deep-tech startup for cross-border scaling support.

Closed

Funds the next development stage, TRL 5 and up, for regenerative-medicine results that already came out of an earlier, completed EU-funded research project.

Closed

Funds consortia that build or adapt generative AI models on large-scale multimodal health data and prove their value with at least two real biomedical use cases.

Funds late-stage clinical trials of vaccines, monoclonal antibodies and antivirals against a named list of lower respiratory tract infection pathogens in sub-Saharan Africa.

Funds clinical trials advancing new or improved antimalarial drug combinations toward registration and access in sub-Saharan Africa.

Funds 4 regional research networks in sub-Saharan Africa to run multi-country clinical trials and rapid outbreak-response research.

Funds Phase IIa-and-later clinical trials of new or shorter TB drug and chemoprophylaxis regimens for adults and children in sub-Saharan Africa.

Funds clinical trials of TB vaccine candidates and licensed vaccines targeting adolescents, adults and vulnerable groups in sub-Saharan Africa.

Funds clinical trials or large-scale implementation research on climate-sensitive water- and vector-borne disease control in sub-Saharan Africa and Europe.

Funds late-stage clinical trials on treating co-infections and co-morbidities in people living with HIV, not HIV itself, across sub-Saharan Africa.

Funds host institutions in sub-Saharan Africa to run Master's fellowships and short courses in epidemiology, biostatistics and infectious-disease modelling, worth up to EUR 90,000 per fellow.

Closed

Funds a coordination project that studies and harmonises how industrial composting plants across Europe handle compostable packaging.

Closed

Funds research consortia, including businesses and startups, that study microbiomes across plants, humans and environments to unlock new food-system applications.

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

Closed

Funds one consortium to run a microbiome research one-stop-shop and coordination hub for EU policymakers and regulators.

Closed

Funds R&D that turns existing food-safety science — molecular methods, genomics, photonics — into deployable tools against food fraud and safety risks.

Closed

Funds development of lab-grown human tissue models, organ-on-chip systems and AI-driven simulations that can replace animal testing in drug and medical device development.